Company Data

Cingulate Inc.

Ticker
CING
Current Price
$5.325 -2.11%
Market Cap
$77.4M
Price Target
Refer to Report
Volume
108.4K
52wk Range
$3.16 - $11.89
Advanced Market Data

Overview

Cingulate Inc is a clinical stage biopharmaceutical company utilizing its proprietary precision timed release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes.